dr. Sharon Vermont says health experts hope the vaccines will be approved by the Food and Drug Administration by the end of the year.
NS. LOUIS — Both Pfizer and Moderna are testing a vaccine for children under 12 years of age.
Mercy Kid’s pediatrician Dr. Sharon Vermont keeps a close eye on the trials.
“We’re all pediatricians about to wait for this vaccine to be approved because that will help our patients tremendously,” Vermont said.
She is awaiting approval of the studies so that she can treat her patients under 12 as soon as possible.
“They’re underway now, and I think from what I’ve heard, the data looks good and is safe and effective for children under 12,” Vermont said.
Pfizer divided their study into three age groups: first ages 5 to 11 years, then ages 2 to 5 years, and then ages 6 months to 2 years.
Moderna’s two-part, dose-escalation study focuses on ages 6 months to 12 years.
“Not only do they have to do the studies, but the FDA has to look at those specific studies for children before they can approve it. That’s why it takes a while,” Vermont said.
Both studies have not yet been approved by the Food and Drug Administration.
Pfizer estimated a September-October time frame to file the vaccine with the FDA for ages 5-11 and plans to track the vaccine for six months to five years shortly after.
“What I heard a few days ago is hopefully by the end of the year, late 2021, but that doesn’t tell us for sure I don’t know if that will mean October or December 31,” Vermont said.
Until then, Dr. Vermont is urging families to mask and for those who can, to get their shot.
“Masks are the only way to keep your kids safe right now, if they are under 12, and if they are 12 and over they should be vaccinated yesterday, and if they weren’t vaccinated yesterday, they should be vaccinated . vaccinated tomorrow,” Vermont said.